Chinese drug sector’s stature grows at major cancer conference
An array of Chinese drug makers showcased positive trial results for new cancer treatments at a major European medical conference, underscoring the expanding international influence of China’s biotech sector. Domestic innovative drugs, particularly antibody-drug conjugates (ADCs), delivered impressive data across multiple tumour types at the European Society for Medical Oncology (Esmo) Congress,…
Read original article on News - South China Morning Post →Related news
-
Huawei’s Tau Scaling Law roll-out reaches base stations in blow to US chip curbs
Technology
AI
China
-
Why Hong Kong rents are hitting records while home price gains lose momentum
Economy
Housing Market
Hong Kong
-
Japan’s US$6 billion port plan aims to revive Bangladesh’s bruised economy
Economy
Trade
Bangladesh
-
Chinese student encouraged by farm owner enrols in master’s programme 6 years later
Good News
China
-
At least 10 dead in Spain after high-speed trains collide
Environment & Nature
Natural Disasters
Spain
-
How Lao Gan Ma, China’s iconic chilli brand, got caught in an AI storm
Technology
AI
China
-
Why China’s ties with Serbia face scrutiny, not severance, after historic Vucic loss
International
Diplomacy
Serbia
-
Stop using Bluey, Australian broadcaster tells Pauline Hanson’s far-right party
Politics
Protests
Australia